Top Suppliers:I want be here



845256-65-7

845256-65-7 structure
845256-65-7 structure
  • Name: MK0731
  • Chemical Name: (R)-2-aMino-2-cyclopropyl-1-((S)-4-(2,5-difluorophenyl)-2-phenyl-2H-pyrrol-1(5H)-yl)ethanone
  • CAS Number: 845256-65-7
  • Molecular Formula: C25H28F3N3O2
  • Molecular Weight: 459.504
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2018-12-18 20:26:33
  • Modify Date: 2024-01-14 19:17:27
  • MK-0731 is a selective, non-competitive and allosteric kinesin spindle protein (KSP) inhibitor with an IC50 of 2.2 nM and a pKa of 7.6. MK-0731 is >20,000 fold selectivity against other kinesins. MK-0731 induces mitotic arrest and induces apoptosis in tumors. MK-0731 provides significant antitumor efficacy[1][2].

Name (R)-2-aMino-2-cyclopropyl-1-((S)-4-(2,5-difluorophenyl)-2-phenyl-2H-pyrrol-1(5H)-yl)ethanone
Synonyms (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methyl-4-piperidinyl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide
1H-Pyrrole-1-carboxamide, 4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methyl-4-piperidinyl]-2,5-dihydro-2-(hydroxymethyl)-N-methyl-2-phenyl-, (2S)-
1H-Pyrrole-1-carboxamide,4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methyl-4-piperidinyl]-2,5-dihydro-2-(hydroxymethyl)-N-methyl-2-phenyl-,(2S)
ALR-3456,MK-0731
(S)-4-(2,5-difluorophenyl)-N-((3R,4S)-3-fluoro-1-Methylpiperidin-4-yl)-2-(hydroxyMethyl)-N-Methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxaMide
MK0731
MFCD11977272
Description MK-0731 is a selective, non-competitive and allosteric kinesin spindle protein (KSP) inhibitor with an IC50 of 2.2 nM and a pKa of 7.6. MK-0731 is >20,000 fold selectivity against other kinesins. MK-0731 induces mitotic arrest and induces apoptosis in tumors. MK-0731 provides significant antitumor efficacy[1][2].
Related Catalog
Target

KSP:2.2 nM (IC50)

In Vitro MK-0731 (0.415-300 nM; 48 小时) 诱导 A2780 细胞凋亡,EC50 为 2.7 nM[1]。 MK-0731 对结合 hERG 通道的亲和力很小 (IC50=20.5 μM)[1]。 MK-0731 能够在细胞中诱导有丝分裂阻滞,IC50 为 19 nM[1]。 Apoptosis Analysis[1] Cell Line: A2780 cells Concentration: 0.415-300 nM Incubation Time: 48 h Result: Induced apoptosis with an EC50 of 2.7 nM.
In Vivo MK-0731 (40 mg/kg/天; 皮下注射; 持续 11 天) 抑制高度过表达 Pgp 的 KB-v 肿瘤的生长,而紫杉醇 (HY-B0015) 没有作用[1]。 MK-0731 (2.5, 5, 10, 20, 40 mg/kg/天; 微型泵) 在 A2780 异种移植小鼠的肿瘤暴露和有丝分裂停滞方面表现出与剂量成比例的增加[1]。 MK-0731 (1 mg/kg/天; 静脉给药) 对于大鼠的 T1/2 为 1 小时,CL 为 66 mL/min•kg,Vss 3 L/kg[1]。 Pharmacokinetic Parameters of MK-0731[1]. rat iv (1 mg/kg) dog iv (0.4 mg/kg) rhesus iv (0.4 mg/kg) T1/2 (h) 1 2 1 CL (mL/min/kg) 66.7 15.1 23.1 Vss (L/kg) 3.0 1.6 2.3 Animal Model: Mice for the dual flank xenograft KB-3-1 and KB-v-1 cells[1] Dosage: 40 mpk Administration: SC; qd×1; for 11 days Result: Inhibited the growth of KB-v tumors that highly overexpress Pgp, whereas Paclitaxel (20 mpk; qd×5) had no effect.
References

[1]. Christopher D Cox, et al. Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer. J Med Chem. 2008 Jul 24;51(14):4239-52.  

[2]. Kyle Holen, et al. A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumors. Invest New Drugs. 2012 Jun;30(3):1088-95.  

Density 1.3±0.1 g/cm3
Boiling Point 590.5±50.0 °C at 760 mmHg
Molecular Formula C25H28F3N3O2
Molecular Weight 459.504
Flash Point 310.9±30.1 °C
Exact Mass 459.213348
PSA 47.02000
LogP 3.61
Vapour Pressure 0.0±1.7 mmHg at 25°C
Index of Refraction 1.615
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.